ARTICLE | Clinical News
Dotarem gadoterate meglumine regulatory update
February 18, 2013 8:00 AM UTC
FDA's Medical Imaging Drugs Advisory Committee unanimously recommended approval of Dotarem gadoterate meglumine from Guerbet to detect and visualize areas with disruption of the blood-brain barrier an...